Pall and Fresenius Kabi team up for prion reduction
This article was originally published in Clinica
Executive Summary
East Hills, New York-based Pall has entered into a five-year commercialisation collaboration with Fresenius Kabi, of Bad Homburg, Germany, aimed at increasing European sales of prion reduction technology for blood transfusions.